|
ZEN003694 Trial is now recruiting patients
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 01:14PM
|
|
The Faces of Cardiovascular Disease
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 02:46PM
|
|
Re: And volume shoots up again...281K traded
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 03:58PM
|
|
Re: So what's the deal agoracom?
|
3
|
Resverlogix Corp.
|
Oct 19, 2016 09:39AM
|
|
Re: A pretty incredible climb so far..... rvx tightly held
|
3
|
Resverlogix Corp.
|
May 31, 2015 01:54PM
|
|
Re: Are there any levels tested that both placebo and treatment group could get improvement on
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 04:13PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 04:22PM
|
|
Re: Warburg Invest Luxembourg
|
3
|
Resverlogix Corp.
|
Dec 01, 2017 10:52AM
|
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
3
|
Resverlogix Corp.
|
Jan 17, 2016 09:54PM
|
|
Top Line Mid Year
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 02:39PM
|
|
Re: Standard of Care in BETonMACE
|
3
|
Resverlogix Corp.
|
Mar 19, 2019 11:04AM
|
|
Re: CEO Blog Update - June 25
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2016 02:15PM
|
|
Re: ReCvr
|
3
|
Resverlogix Corp.
|
Sep 25, 2017 01:59PM
|
|
Re: Transcend - The Enabler
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 28, 2016 09:42AM
|
|
Re: Trial
|
3
|
Zenith Epigenetics
|
Feb 09, 2020 11:00AM
|
|
Re: Kelsee left me a message on my VM...
|
3
|
Resverlogix Corp.
|
May 22, 2019 06:46PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Sep 02, 2017 02:21PM
|
|
Re: Resverlogix Reasonable Expectations
|
3
|
Resverlogix Corp.
|
Feb 11, 2016 01:59PM
|
|
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What’s Old Is New Again
|
3
|
Resverlogix Corp.
|
Feb 02, 2019 10:51AM
|
|
Re: Richmond Club clarification please...
|
3
|
Resverlogix Corp.
|
Jun 26, 2015 04:19PM
|
